Published in Eur Respir J on February 01, 2004
Pathophysiology of sleep apnea. Physiol Rev (2010) 4.69
Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med (2009) 3.24
Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep (2009) 1.76
Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation? Sleep Med Clin (2007) 1.04
Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children. Front Neurol (2012) 0.99
Prognosis and cardiovascular morbidity and mortality in prospective study of hypertensive patients with obstructive sleep apnea syndrome in St Petersburg, Russia. Med Sci Monit (2011) 0.97
Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processing. Antioxid Redox Signal (2011) 0.94
Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options. Nat Sci Sleep (2010) 0.87
The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia. Respir Physiol Neurobiol (2014) 0.85
Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients. J Card Fail (2013) 0.83
Serum angiotensin converting enzyme and the obstructive sleep apnea hypopnea syndrome. J Clin Sleep Med (2008) 0.79
Obstructive sleep apnea - management update. Neuropsychiatr Dis Treat (2006) 0.77
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy. Graefes Arch Clin Exp Ophthalmol (2014) 0.76
The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea. J Thorac Dis (2016) 0.75
How best to determine optimal nasal CPAP in patients with OSAH? Thorax (2006) 0.75
Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation (2003) 2.71
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Correlated and uncorrelated regions in heart-rate fluctuations during sleep. Phys Rev Lett (2000) 1.91
Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation (2000) 1.84
Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J (2010) 1.78
Standards for biomedical signal databases. IEEE Eng Med Biol Mag (2001) 1.71
COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract (2014) 1.63
[Guidelines for diagnosis and treatment of asthma patients]. Pneumologie (2006) 1.59
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med (2000) 1.54
Parathyroid function following ligation of the inferior thyroid arteries during bilateral subtotal thyroidectomy. Br J Surg (1994) 1.52
Enzymatic conversion of adenosine to inosine and to N1-methylinosine in transfer RNAs: a review. Biochimie (1996) 1.51
Growth, Gravitropism, and Endogenous Ion Currents of Cress Roots (Lepidium sativum L.) : Measurements Using a Novel Three-Dimensional Recording Probe. Plant Physiol (1992) 1.49
[Management of sleep-related abnormal breathing by cardiologists and hospital departments of cardiology]. Dtsch Med Wochenschr (2010) 1.40
[Rare diseases in pulmonary medicine and its challenges]. Pneumologie (2012) 1.39
[beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr (2007) 1.39
[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]. Pneumologie (1999) 1.38
[Chronic obstructive pulmonary disease (COPD)]. Dtsch Med Wochenschr (2012) 1.38
Interrater reliability between scorers from eight European sleep laboratories in subjects with different sleep disorders. J Sleep Res (2004) 1.33
Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg (2001) 1.32
Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med (1997) 1.29
Effect of sleep position and sleep stage on the collapsibility of the upper airways in patients with sleep apnea. Sleep (2001) 1.26
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med (1996) 1.22
Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology (1991) 1.19
Electrophoretic characterization of wheat grain allergens from different cultivars involved in bakers' asthma. Electrophoresis (1993) 1.16
Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Med (2000) 1.16
The SIESTA project polygraphic and clinical database. IEEE Eng Med Biol Mag (2001) 1.16
Suppression of pulmonary innate host defence in smokers. Thorax (2008) 1.12
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11
Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol (1997) 1.09
Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J (2006) 1.08
Arousal in patients with gastro-oesophageal reflux and sleep apnoea. Eur Respir J (1999) 1.06
A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology (1999) 1.05
Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol (1985) (1998) 1.05
Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton. J Biol Chem (1989) 1.05
Linking sociological with physiological data: the model of effort-reward imbalance at work. Acta Physiol Scand Suppl (1997) 1.04
Automatic CPAP titration with different self-setting devices in patients with obstructive sleep apnoea. Eur Respir J (2004) 1.04
Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med (1999) 1.04
Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology (1996) 1.03
TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens (2005) 1.03
Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) (1993) 1.02
Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling. Eur Respir J (2005) 1.00
Nonrandom variability of respiration during sleep in healthy humans. Sleep (2005) 1.00
Humidifier lung and humidifier fever. Lung (1988) 0.99
Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proc Natl Acad Sci U S A (1990) 0.99
Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol (2000) 0.97
Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase. J Clin Invest (1991) 0.97
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy. Chest (1996) 0.96
ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. Clin Nutr (2006) 0.96
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clin Pharmacol Ther (2012) 0.95
Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur Respir J (1996) 0.95
Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest (1979) 0.95
The relationship between normal lung sounds, age, and gender. Am J Respir Crit Care Med (2000) 0.95
A review of signals used in sleep analysis. Physiol Meas (2013) 0.94
Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis. Nature (1981) 0.94
Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord (2002) 0.93
Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res (1996) 0.93
Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine. Eur Respir J (2002) 0.93
Occupational asthma in hairdressers: results of inhalation tests with bleaching powder. Int Arch Occup Environ Health (1997) 0.92
Peripheral airspace dimensions in patients with COPD. Chest (1995) 0.92
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele. Mol Cell Biol (1990) 0.92
A prospective polysomnographic study on the evolution of complex sleep apnoea. Eur Respir J (2011) 0.92
[Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET]. Dtsch Med Wochenschr (2010) 0.91
[Health effects of particulate matter exposure: current scientific knowledge]. Pneumologie (2009) 0.91
Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur Respir J (1995) 0.91
Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect (1997) 0.91
The SleepStrip: an apnoea screener for the early detection of sleep apnoea syndrome. Eur Respir J (2002) 0.91
Airflow limitation, lung volumes and systemic inflammation in a general population. Eur Respir J (2011) 0.91
Automatic screening of obstructive sleep apnea from the ECG based on empirical mode decomposition and wavelet analysis. Physiol Meas (2010) 0.89
Functional significance of cardiac reinnervation in heart transplant recipients. J Heart Lung Transplant (1999) 0.89
Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin Diagn Lab Immunol (2001) 0.89
Respiratory arousals in mild obstructive sleep apnea syndrome. Sleep (1999) 0.89
The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Transpl Infect Dis (2001) 0.89
Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group. Eur Respir J (2000) 0.89
Sleep fragmentation and daytime vigilance in patients with OSA treated by surgical maxillomandibular advancement compared to CPAP therapy. J Sleep Res (1998) 0.88
A possible mechanism of the ovulation-inhibiting effect of chlormadinone acetate in the rat. J Endocrinol (1968) 0.87
Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection? Eur Respir J (2002) 0.87
Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology (2001) 0.87
Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr (1976) 0.87
Analysis of sleep fragmentation and sleep structure in patients with sleep apnea and normal volunteers. Conf Proc IEEE Eng Med Biol Soc (2005) 0.86
Manifestations and consequences of obstructive sleep apnoea. Eur Respir J (1995) 0.86
Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis. Am J Respir Crit Care Med (2001) 0.86
Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity. Am J Respir Crit Care Med (1999) 0.86
Comparability of pulse oximeters used in sleep medicine for the screening of OSA. Physiol Meas (2010) 0.86
Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Curr Med Res Opin (2007) 0.85
SENSATION remote monitoring system for enabling the "anytime, anywhere" monitoring of patients with selected sleep disorders. Conf Proc IEEE Eng Med Biol Soc (2006) 0.85
Co-existence of unrelated peptides in oxytocin and vasopressin terminals of rat neurohypophyses: immunoreactive methionine-enkephalin-, leucine-enkephalin- and cholecystokinin-like substances. Neuroscience (1983) 0.85
Neutrophil proteinases and rhDNase therapy in cystic fibrosis. Eur Respir J (1996) 0.85
Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J (1997) 0.84
Treatment options for sleep apnoea. Drugs (2001) 0.84
Insulin release in rats 1 and 5 days after hypophysectomy. Horm Res (1981) 0.84
[Machine-assisted detection of individually effective minimal CPAP pressure using the Vitalog HMS 5000 monitor]. Pneumologie (1995) 0.84
Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease. Am J Pathol (1982) 0.84